TheraJect, Inc. logo — Enhancing Vaccine Efficacy and Expanding Global Access with...

TheraJect, Inc.

Enhancing Vaccine Efficacy and Expanding Global Access with Innovative, Needle-Free Transdermal Technology

Founded 2002 1 employees Grant Total: $500.00K Biotechnology, Health Care +1

General Information

Company Name TheraJect, Inc.
Founded Year 2002
Employees 1
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with TheraJect, Inc.. To contact TheraJect, Inc., visit theraject.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About TheraJect, Inc.

TheraJect, Inc. is a biopharmaceutical company founded in 2002 with the slogan "Enhancing Vaccine Efficacy and Expanding Global Access with Innovative, Needle-Free Transdermal Technology." Specializing in drug delivery, including vaccines, through innovative needle-free transdermal technology, TheraJect aims to improve the effectiveness of current vaccines, enable the development of new vaccines, and broaden the global vaccine market.

The last investment received by TheraJect, Inc. was a $500.00K Grant investment on 06 August 2012, provided by the National Science Foundation.

TheraJect operates within the Biotechnology, Health Care, and Pharmaceutical industries, positioning itself at the forefront of innovation in vaccine delivery. With a focus on enhancing vaccine efficacy and expanding global access, TheraJect presents a promising venture for investors seeking opportunities in the biopharmaceutical sector.

Taxonomy: biopharmaceutical, preclinical stage, drug delivery, vaccines, transdermal technology, needle-free, vaccine efficacy, global access, innovation, pharmaceutical industry, immunization, global health, medical advancements

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $500.00K 1
National Science Foundation
06 Aug 2012

TheraJect, Inc. Alternatives & Competitors

TheraJect, Inc. vs
Stablepharma Limited
Stablepharma Limited United Kingdom

Stablepharma develops fridge-free, extended shelf-life versions of vaccines and pharmaceuticals to r...

22 employees
Biotechnology, Health Care
TheraJect, Inc. vs

Pioneering needle-free mucosal vaccines for natural and robust immunity.

Venture round
Biotechnology, Health Care
TheraJect, Inc. vs
Vaxxas
Vaxxas Australia

Vaxxas is commercializing novel technology that dramatically enhances the performance of existing an...

Grant
128 employees
Biotechnology, Health Care

FAQ About TheraJect, Inc.

Enhancing Vaccine Efficacy and Expanding Global Access with Innovative, Needle-Free Transdermal Technology
TheraJect, Inc. was founded in 2002.
TheraJect, Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical, preclinical stage, drug delivery and vaccines.
TheraJect, Inc. has approximately 1 employees.
TheraJect, Inc. has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Grant.
Top alternatives and competitors to TheraJect, Inc. include Stablepharma Limited, Mucosis, Vaxxas, FLUGEN, INC., Stabilitech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TheraJect, Inc. and Stablepharma Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TheraJect, Inc., https://bouncewatch.com/company/theraject-inc, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes